Related Experiment Video
Updated: Aug 7, 2026
07:59
Demystifying In Vivo Bioluminescence Imaging of a Chagas Disease Mouse Model for Drug Efficacy Studies
Published on: May 31, 2024
[Venous endothelial dysfunction in Chagas' disease patients without heart failure]
Rodrigo Della Méa Plentz1, Maria Claudia Irigoyen, Andreia Simone Muller
1Universidade Federal de São Paulo, Instituto do Coração, Hospital das Clínicas, FMUSP, São Paulo, SP. roplentz@yahoo.com.br
Arquivos Brasileiros De Cardiologia
|July 1, 2006
Summary
Chagas' disease patients without heart failure exhibit venous endothelial dysfunction. This study highlights early vascular changes in Chagas' disease, impacting venous function.
Area of Science:
- Cardiovascular Physiology
- Vascular Biology
- Tropical Medicine
Context:
- Chagas' disease is a parasitic infection with significant cardiovascular implications.
- Endothelial dysfunction is an early marker of cardiovascular disease.
- Previous research has not fully elucidated venous endothelial function in Chagas' disease patients without overt heart failure.
Purpose:
- To investigate venous endothelial function in individuals with Chagas' disease who have not yet developed heart failure.
- To compare venous endothelial function between Chagas' disease patients and a healthy control group.
Summary:
- The study utilized the Dorsal Hand Vein Compliance Technique to assess venous endothelial function.
- Patients with Chagas' disease required higher phenylephrine doses for pre-constriction and showed significantly reduced endothelium-dependent venous dilation compared to controls.
- No significant differences were found in endothelium-independent venous dilation, suggesting a specific impairment of endothelial-dependent mechanisms.
Impact:
- Identifies venous endothelial dysfunction as a characteristic of Chagas' disease, even in the absence of heart failure.
- Suggests that endothelial dysfunction may be an early pathogenic mechanism in Chagas' disease.
- Provides a basis for further research into therapeutic strategies targeting endothelial function in Chagas' disease.
Related Concept Videos
01:22American Trypanosomiasis
Chagas disease, or American trypanosomiasis, is a vector-borne parasitic infection caused by Trypanosoma cruzi, a flagellated protozoan (kinetoplastid) of the family Trypanosomatidae. The disease is endemic in Latin America, although cases are increasingly reported worldwide due to human migration. Transmission most commonly occurs when feces of infected triatomine bugs contaminate bite wounds or mucosal surfaces; additional routes include congenital, transfusional, transplant-related, and oral...
01:29Heart Failure II: Pathophysiology
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
01:27Assessment of the Cardiovascular System III: Palpation
Palpation involves feeling the body to evaluate texture, size, consistency, and tenderness for assessing cardiovascular health. The following steps are organized in a head-to-toe order:
Jugular Venous Pressure (JVP) Measurement
Position the patient at a thirty- to forty-five-degree angle or in a semi-fowler's position. Look for the highest point of pulsation in the internal jugular vein and measure the vertical distance to the angle of Loius or sternal angle. A normal JVP is 3-4 cm above the...
Jugular Venous Pressure (JVP) Measurement
Position the patient at a thirty- to forty-five-degree angle or in a semi-fowler's position. Look for the highest point of pulsation in the internal jugular vein and measure the vertical distance to the angle of Loius or sternal angle. A normal JVP is 3-4 cm above the...
01:17Pathophysiology of Heart Failure
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
01:26Heart Failure III: Clinical Manifestations
Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
01:21Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...